FDA Documents of Novartis Pharma AG
Novartis Pharma AG is an organization that has been audited by the FDA 30 times between 2000 and 2024 across all 6 sites.
Documents
FDA 483 Novartis Pharma AG, Basel | 2022
Out-of-stock
Issued on: Aug 30, 2022
Human Drug Form 483
FDA 483 Novartis Pharma AG, Basel | 2019
Out-of-stock
Issued on: Aug 29, 2019
Human Drug Form 483
FDA 483 Novartis Pharma AG, Basel | 2017
Out-of-stock
Issued on: Jul 6, 2017
Human Drug Form 483
FDA 483 Novartis Pharma AG, Basel | 2012
Out-of-stock
Issued on: Jul 26, 2012
Human Drug Form 483
FDA 483 Novartis Pharma AG, Basel | 2009
Out-of-stock
Issued on: May 8, 2009
Human Drug Form 483
FDA 483 Novartis Pharma AG, Basel | 2008
Out-of-stock
Issued on: Nov 21, 2008
Human Drug Form 483
FDA 483 Novartis Pharma AG, Basel | 2008
Out-of-stock
Issued on: Jul 11, 2008
Human Drug Form 483
FDA 483 Novartis Pharma AG, Basel | 2005
Out-of-stock
Issued on: Sep 30, 2005
Human Drug Form 483
FDA 483 Novartis Pharma AG, Basel | 2005
Out-of-stock
Issued on: Jun 2, 2005
Animal Drugs & Feed Form 483
FDA 483 Novartis Pharma AG, Basel | 2005
Out-of-stock
Issued on: Jun 2, 2005
Animal Drugs & Feed Form 483
FDA 483 Novartis Pharma AG, Basel | 2003
Out-of-stock
Issued on: Mar 24, 2003
Biologic Form 483
FDA 483 Novartis Pharma AG, Basel | 2001
Out-of-stock
Issued on: May 10, 2001
Biologic Form 483
FDA 483 Novartis Pharma AG, Basel | 2001
Out-of-stock
Issued on: May 8, 2001
Human Drug Form 483
FDA 483 Novartis Pharma AG, Basel | 2000
Out-of-stock
Issued on: Oct 30, 2000
Human Drug Form 483
FDA 483 Novartis Pharma AG, Basel | 2000
Out-of-stock
Issued on: Oct 19, 2000
Human Drug Form 483
FDA Investigators(40)
- David L. Chon, FDA Investigator
- Yasamin Ameri, FDA Investigator
- Maxwell L. Van Tassell, FDA Investigator
- Van Tassell, Maxwell L, FDA Investigator
- Robert J. Martin, FDA Investigator
- Li-Hong P. Yeh, FDA Investigator
- Mohsen Rajabi Abhari, FDA Investigator
- Li-Hong Yeh, FDA Investigator
- Rajabi Abhari, Mohsen, FDA Investigator
- Stephen D. Brown, FDA Investigator
- Yanming An, FDA Investigator
- Omotunde O. Osunsanmi, FDA Investigator
- Thomas E. Friel, FDA Investigator
- Marie F. Morin, FDA Investigator
- Prabhu P. Raju, FDA Investigator
- Brandon C. Heitmeier, FDA Investigator
- Helen B. Ricalde, FDA Investigator
- Susanne M. Richardson, FDA Investigator
- Patricia F. Hughes Troost, FDA Investigator
- Anastasia G. Lolas, FDA Investigator
- Hughes Troost, Patricia F, FDA Investigator
- Minh D. Phan, FDA Investigator
- Katherine E. Jacobitz, FDA Investigator
- Kim L. Thomas Cruse, FDA Investigator
- Thomas Cruse, Kim L, FDA Investigator
- Peter R. Lenahan, FDA Investigator
- Sharon K. Thoma, FDA Investigator
- Sid B. Priesmeyer, FDA Investigator
- Kevin D. Kallander, FDA Investigator
- Gwyn G. Dickinson, FDA Investigator
- Kent C. Faul, FDA Investigator
- Carl Anderson, FDA Investigator
- Rebecca Rodriguez, FDA Investigator
- Charles M. Edwards, FDA Investigator
- Julie D. Bringger, FDA Investigator
- Ann M. Montemurro, FDA Investigator
- Robert C. Coleman, FDA Investigator
- Charles I. Ahn, FDA Investigator
- Jose A. Cruz Gonzalez, FDA Investigator
- Cruz Gonzalez, Jose A, FDA Investigator